Experts worry early detection tests like Galleri and CancerGuard are unproven and could drive up health care costs by ...
OPERA-02: a phase 3 randomized, double-blind, active-controlled study of palazestrant with ribociclib versus letrozole with ribociclib for the first-line treatment of ER+, HER2- advanced breast cancer ...
Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted ...
Researchers at the ESMO Congress said they want to confirm their findings in a prospective randomized controlled trial.
SAN DIEGO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the design and development of next-generation medicines for cancer, ...
Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Flowers and candles are placed around crosses on ...
SAN DIEGO, October 7, 2025 – ( Investorideas.com Newswire) Breaking Medical Tech News- Aethlon Medical, Inc. (Nasdaq: AEMD) today provided observations on the preliminary changes in extracellular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback